Published in Am J Cardiol on February 01, 1993
Dealing with in-stent restenosis. Heart (1998) 0.91
Current understanding of coronary in-stent restenosis. Pathophysiology, clinical presentation, diagnostic work-up, and management. Z Kardiol (2005) 0.79
Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty. Tex Heart Inst J (1995) 0.77
Early and intermediate term clinical outcome after multiple coronary stenting. Heart (1998) 0.77
BEta versus Gamma Utrecht Trial-Cypher (BEGUT-CYPHER): Is intracoronary brachytherapy still superior to drug-eluting stents? Neth Heart J (2004) 0.77
New recipes for in-stent restenosis: cut, grate, roast, or sandwich the neointima? Heart (2000) 0.76
Catheter based intracoronary brachytherapy leads to increased platelet activation. Heart (2004) 0.75
Intracoronary brachytherapy for the treatment of complex in-stent restenosis. Heart (2005) 0.75
Fractional flow reserve for the prediction of cardiac events after coronary stent implantation: results of a multivariate analysis. Heart (2005) 0.75
Clinical and angiographic outcome in patients with in-stent restenosis and repeat target lesion revascularisation in small coronary arteries. Heart (2000) 0.75
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med (1994) 7.96
The effects of antihypertensive therapy on the quality of life. N Engl J Med (1986) 5.32
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (1994) 4.94
The physician's role in health promotion--a survey of primary-care practitioners. N Engl J Med (1983) 4.82
Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke (1994) 4.45
Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc Natl Acad Sci U S A (1985) 3.93
Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation (1996) 3.82
Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation (1996) 3.58
Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med (1996) 3.40
Specificity of salivary-bacterial interactions: role of terminal sialic acid residues in the interaction of salivary glycoproteins with Streptococcus sanguis and Streptococcus mutans. Infect Immun (1978) 3.12
Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med (1990) 3.12
The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol (2000) 2.99
Coronary artery imaging with intravascular high-frequency ultrasound. Circulation (1990) 2.97
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med (1987) 2.88
Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med (1997) 2.86
Specificity of salivary-bacterial interactions: II. Evidence for a lectin on Streptococcus sanguis with specificity for a NeuAc alpha 2, 3Ga1 beta 1, 3Ga1NAc sequence. Biochem Biophys Res Commun (1982) 2.81
Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation (2001) 2.77
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol (2001) 2.74
Can coronary flow parameters after stent placement predict restenosis? Cathet Cardiovasc Diagn (1995) 2.69
Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation (1999) 2.67
Implantation of balloon-expandable intravascular grafts by catheterization in pulmonary arteries and systemic veins. Circulation (1988) 2.65
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation (1989) 2.56
Respiratory syncytial virus polypeptides: their location in the virion. Virology (1979) 2.53
The physician's role in health promotion revisited--a survey of primary care practitioners. N Engl J Med (1996) 2.52
The relationship of psychosocial factors to coronary heart disease in the Framingham study. I. Methods and risk factors. Am J Epidemiol (1978) 2.47
Delayed respiratory arrest in combined spinal-epidural anesthesia. Case report. Reg Anesth (1995) 2.33
Benefit of selective respiratory muscle training on exercise capacity in patients with chronic congestive heart failure. Circulation (1995) 2.32
The American College of Cardiology National Database: progress and challenges. American College of Cardiology Database Committee. J Am Coll Cardiol (1997) 2.31
Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation (2000) 2.28
Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation (1991) 2.23
In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol (1998) 2.23
Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation (2001) 2.22
Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol (2001) 2.22
A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. N Engl J Med (1993) 2.18
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med (1987) 2.18
Analysis of coronary angioplasty practice in the United States with an insurance-claims data base. Circulation (1993) 2.16
Role of salivary mucins in the protection of the oral cavity. J Oral Pathol (1982) 2.14
Influence of colony type on susceptibility of gonococci to killing by human serum. J Immunol (1976) 2.14
Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation (2001) 2.12
Cost-efficacy modeling of catheter reuse for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol (1996) 2.11
Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J Biol Chem (1993) 2.11
Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation (2001) 2.10
Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med (1997) 2.09
Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry. Am J Cardiol (1992) 2.08
Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure. Circulation (1995) 2.06
Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. Circulation (1997) 2.05
Immediate sealing of arterial puncture sites after cardiac catheterization and coronary interventions: initial U.S. feasibility trial using the Duett vascular closure device. Catheter Cardiovasc Interv (2000) 2.04
Health promotion and the compression of morbidity. Lancet (1989) 2.02
Impaired left ventricular diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography. Circulation (1981) 2.00
Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation (1996) 1.99
Theory of the electrokinetic behavior of human erythrocytes. Biophys J (1983) 1.97
Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol (1995) 1.95
Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol (1995) 1.93
Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens. Infect Immun (1991) 1.93
Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv (2001) 1.93
Relationship of job strain and iso-strain to health status in a cohort of women in the United States. Scand J Work Environ Health (1998) 1.92
The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol (1998) 1.91
Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J (1990) 1.90
Inescapable versus escapable shock modulates long-term potentiation in the rat hippocampus. Science (1989) 1.90
The relationship of psychosocial factors to coronary heart disease in the Framingham study. II. Prevalence of coronary heart disease. Am J Epidemiol (1978) 1.88
Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955--1977. Semin Arthritis Rheum (1979) 1.87
The Coventry Award. Polymerase chain reaction detection of bacterial infection in total knee arthroplasty. Clin Orthop Relat Res (1996) 1.83
Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol (1992) 1.82
Seeding of intravascular stents with genetically engineered endothelial cells. Circulation (1989) 1.82
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation (1985) 1.81
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy. Circulation (2000) 1.79
Kinetics of the respiratory syncytial virus growth cycle in HeLa cells. Arch Gesamte Virusforsch (1969) 1.78
Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group. Circulation (1994) 1.76
Rotational coronary atherectomy after unsuccessful coronary balloon angioplasty. Am J Cardiol (1993) 1.71
Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J (2002) 1.69
Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade. Am J Cardiol (2000) 1.69
Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial. Circulation (2000) 1.65
Respiratory syncytial virus polypeptides. III. The envelope-associated proteins. J Gen Virol (1983) 1.65
Femoral artery hemostasis using an implantable device (Angio-Seal) after coronary angioplasty. Cathet Cardiovasc Diagn (1996) 1.65
Incidence, management, and outcome of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol (2000) 1.64
Salivary histatin 5: dependence of sequence, chain length, and helical conformation for candidacidal activity. J Biol Chem (1990) 1.63
Experimental cyanide encephalopathy: electron microscopic observations of early lesions in white matter. J Neuropathol Exp Neurol (1967) 1.63
Antigen and polypeptide synthesis by temperature-sensitive mutants of respiratory syncytial virus. J Gen Virol (1981) 1.63
Treatment of calcified coronary lesions with Palmaz-Schatz stents. An intravascular ultrasound study. Eur Heart J (1998) 1.62
Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage. Arthritis Rheum (1977) 1.62
Isolation and immunochemical characterization of the group-specific antigen of Streptococcus mutants 6715. Infect Immun (1975) 1.62
Intensity and frequency: dimensions underlying positive and negative affect. J Pers Soc Psychol (1985) 1.60
Characterization of salivary alpha-amylase binding to Streptococcus sanguis. Infect Immun (1989) 1.60
Polypeptides of respiratory syncytial virus. J Virol (1977) 1.60
Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol (2000) 1.60
Electrode ranking of "place pitch" and speech recognition in electrical hearing. J Acoust Soc Am (1995) 1.59
Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol (1992) 1.59